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Introduction

Discussion

Pre-Operative Imaging

As previously mentioned, phyllodes tumors themselves are fairly rare among all tumors
of the breast, however coexistence of in situ or invasive cancer within the background of
these largely benign tumors is exceedingly rare. Review of the literature reveals very
few of these cases have been identified, with breast carcinoma being found in at most
1-2% of all phyllodes tumors. As noted by Wu et. al, most of the previously published
cases have identified breast carcinoma within the background of either benign or
malignant phyllodes features, few have seen this pathology arise from the borderline
pathologic subtype of phyllodes tumors.4

Phyllodes tumors are uncommon, often benign, malignancies of the breast and account
for approximately 0.5% of all breast malignancies. These tumors were first described in
1838 by Johannes Muller as cystosarcoma phyllodes and were later more aptly
renamed phyllodes tumors (as they were neither cystic nor sarcomatous).1 As a mixed
connective tissue and epithelial tumor, these behave similar to benign fibroadenomas,
though their growth is much more rapid and they tend to occur in older patients.2
Hallmarked by their large size at presentation, these tumors average between 4 and 7
cm at the time of diagnosis. The only known risk factor for development of a phyllodes
tumor is Li-Fraumeni syndrome.1 Pathology of a phyllodes tumor is similar to that of a
fibroadenoma though with increased cellularity and added whorled stroma which forms
large clefts lined by epithelium resembling leaf-like clusters.2 Mammography and
ultrasound are unable to distinguish these tumors from a fibroadenoma as they show
similar rounded borders. As a result, core needle biopsy is the preferred method of
diagnosis, followed by complete wide excision with 1 cm margins to prevent local
recurrence. Lymph node dissection is not required as lymph node metastasis is rare.3
Review of SEER data showed only 8 of 498 women with phyllodes tumors had nodal
involvement.1 50% of phyllodes tumors are entirely benign, however the remaining 50%
are split between histologic designations of borderline (25%) and malignant (25%) after
excision. Borderline and malignant histologies are characterized by increased stromal
cellularity, atypia, mitotic rate, and presence of stromal overgrowth with infiltrative
margins. These borderline and malignant tumors tend to have courses most similar to
sarcoma of the trunk and spread hematogenously.1 Only rarely in the literature have
cases of invasive ductal cancer been reported in the background of a benign or
borderline phyllodes histology.

Previous reports have noted this pathology in a wide range of patients, the youngest
reported as 26 years old,5 though median age has been estimated between 40 and 50
years old.6 The largest retrospective study to date performed by Co et al. in southern
China reviewed 557 cases of phyllodes tumors over a 20 year regional case history.6
This study revealed 6 cases of carcinoma incidentally found in phyllodes tumors with
carcinoma more commonly found in malignant phyllodes subtypes (4.7%) than benign
or borderline subtypes (0.6%). The investigators of this study found no association of
high grade DCIS with the pathologic subtype of phyllodes tumor within which it was
found.6
A single study has reported concomitant appearance of invasive cancer and phyllodes
tumors in different breasts. Neto, et al. reported a case of synchronous, but
pathologically independent tumors; the tumor pathology of one breast was confirmed as
phyllodes, while tumor pathology of the other breast was confirmed as invasive ductal
carcinoma. This case, however, seems to be an exceedingly rare coincidence as its
findings were not noted in any other studies.7

A

Case Description

B

A pleasant 79 year old Caucasian female presented to the breast clinic after noticing a
rapidly enlarging lump in her left breast over the six weeks prior to her presentation. Her
medical history was significant for a previous left breast biopsy many years prior, which
was benign. She had no other personal or family factors placing her at increased risk of
developing breast cancer. Prior to evaluation in the office, the patient was sent for
bilateral mammography and ultrasound studies of her breasts to gain insight into her
newly discovered left breast mass. The patient’s last mammogram had been five years
prior and normal. Left breast imaging was concerning for possible malignancy (Figure
1). On examination in the office the patient was noted to have a visible & readily
palpable mass along the entire outer edge of her left breast corresponding to the area
of concern on the mammogram. No other palpable masses, skin, nipple, or axillary
changes were noted. As a result, the patient was sent for ultrasound guided core
needle biopsy. Biopsy pathology demonstrated a fibroepithelial lesion with cellular
stroma and increased mitosis suspicious for a phyllodes tumor. As a result, preoperative clearances were obtained and the patient was scheduled for a left breast
lumpectomy/excision of mass.
In the operating room, the patient’s left breast mass was removed without any unusual
events. The mass was easily dissected away from normal surrounding breast tissue
circumferentially. Examination of the gross specimen noted it contained both solid and
cystic components.
Pathologic analysis noted 8.8 x 7.5 x. 6.3 cm mass with 0.1-1cm margins of normal
tissue surrounding tumor cells. Phyllodes tumor predominated with stromal overgrowth
and infiltration into surrounding breast parenchyma. Core needle biopsy site was
visualized within the phyllodes tumor. Area of invasive ductal carcinoma was also noted
with poorly differentiated micropapillary features measuring 1.9 cm at its largest focus
of invasion, though the sample analysis was unable to elucidate whether or not there
were multiple foci of invasion or one contiguous area of concern. There was also an
additional area of ductal carcinoma in situ (DCIS) with clinging and cribriform patterns
that was noted within the phyllodes tumor. All margins (including skin) were noted to be
free of invasive and in situ carcinoma. Immunoperoxidase studies were ER+, PR+,
HER2-. Based on the patient’s pathologic analysis, her focus of invasive carcinoma was
classified as T1C, with unknown nodal status.
The patient’s case was discussed at interdisciplinary tumor board due to its rarity of
presentation. Based on the tumor board’s consensus, the patient was recommended to
have a completion left mastectomy with sentinel lymph node biopsy, to which she was
initially agreeable. However after several attempts to contact the patient, she was
ultimately lost to follow-up.

There remains no clear pathway for malignant transformation of phyllodes tumors into
breast carcinoma. Steps to characterize the molecular relationship between these two
different pathologies were taken by Macher-Goeppinger et al., who isolated and
examined DNA from the epithelial and stromal components of phyllodes tumors and
invasive ductal carcinoma cells. Close examination demonstrated lack of clonality
between phyllodes tumors and invasive ductal carcinoma. This preliminary analysis
suggests that these two entities found concomitantly represent a true collision tumor. 8
Of ongoing concern regarding development of breast carcinoma within phyllodes tumor,
is the type of treatment strategy that will best benefit the patient. While no deaths have
yet been reported of patients diagnosed with invasive cancer and concomitant phyllodes
tumor, objective data lacks regarding which treatment options work best in patients with
this unique pathology. Most investigators identifying these lesions have pursued reexcision with lymph node sampling with all further treatment guided by the
carcinomatous component of the tumor.5

Conclusions
Though phyllodes tumors are largely considered benign breast lesions, potential for
underlying malignant invasive breast carcinoma exists. The finding of invasive
carcinoma within phyllodes may be rare, however its possibility warrants careful
pathologic examination, particularly of the epithelial components of the excised tumor.
While no clear treatment consensus exists, patients seem to benefit from treatment
guided by the carcinomatous component of the tumor. Systematic review of the
published literature regarding invasive carcinoma in phyllodes tumor would help to
better guide diagnosis and treatment of patients with this condition.
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Figure 1: Pre-operative 2D mammography showing a large 5cm lobulated mass in the anterior upper outer
quadrant of the left breast with linear stranding posterior to the mass. There are also linear calcifications in a
branching pattern as noted along the outer aspect of the mass. Biopsy clip from previous biopsy is noted in the
middle third of the central left breast. A. Left breast magnification of medial-lateral view. B. Left breast magnification
of craniocaudal view C. L breast craniocaudal view demonstration linear calcifications in a branching pattern D. Left
breast ultrasound demonstrating large lobulated mass at 3:00 position about 3 cm from the nipple. Ultrasound
measured mass as 60 x 42 x 54 mm containing color flow and corresponding to the lump palpable on physical
examination.

References
1.Mulholland, MW., Lillemoe, K., Doherty, G. (2017) Chapter 74: Breast Disease. Greenfield’s Surgery. 6th Ed. (pp. 1331 - 1332)
Wolters Kluwer.
2.Beauchamp, R.D., Evers, B.M., Mattox, K., Townsend, C. (2017) Chapter 34: Diseases of the Breast. Sabiston Textbook of
Surgery. 20th Ed. (pp. 841-842) Elsevier.
3.Cameron, J.L., Cameron, A.M. (2020) Benign Breast Disease. Current Surgical Therapy. 13th Ed. (pp. 658) Elsevier.
4.Wu, D., Zhang, H., Guo, L., et al.. Invasive ductal carcinoma within borderline phyllodes tumor with lymph node metastases: A
case report and review of the literature. Oncology Letters. (2016). 11(4), 2502 - 2506. https://doi.org/10.3892/ol.2016.4238
5.Parfitt, J., Armstrong, C., O’Malley, et al. In-situ and invasive carcinoma within a phyllodes tumor associated with lymph node
metastases. World J of Surg Onc (2004). 2(46). https://doi.org/10.1186/1477-7819-2-46
6.Co, M., Tse, G., Chen, C., et al. Coexistence of Ductal Carcinoma Within Mammary Phyllodes Tumor: A Review of 557 Cases
From a 20-year Region-wide Database in Hong Kong and Southern China. Clinical Breast Ca. (2018). 18(3); 421-425.
https://doi.org/10.1016/j.clbc.2017.06.001
7.Neto, GB., Rossetti, C., Souza, N., et al. Coexistence of benign phyllodes tumor and invasive ductal carcinoma in distinct breasts:
case report. European Journal of Medical Research. (2012) 17(8), 1-4. DOI:10.1186/2047-783X-17-8
8.Macher-Goeppinger, S., Marme, F., Goeppert, B. Invasive ductal breast cancer within a malignant phyllodes tumor: case report
and assessment of clonality. Human Pathology. (2010). 41(2), 293-296. https://doi.org/10.1016/j.humpath.2009.08.006

